mTOR-dependent TFEB activation and TFEB overexpression enhance autophagy-lysosome pathway and ameliorate Alzheimer's disease-like pathology in diabetic encephalopathy.
Lizhen ChengYixin ChenDonghao GuoYuan ZhongWei LiYijia LinYa MiaoPublished in: Cell communication and signaling : CCS (2023)
Our findings suggest that impaired ALP is responsible for the aggravation of AD-like pathology in T2DM. We propose that mTOR-dependent TFEB activation and TFEB overexpression are promising therapeutic strategies for DE, as they enhance the clearance of ALP-targeted AD-like pathology and alleviate neuronal apoptosis. Our study provides insight into the underlying mechanisms of DE and offers potential avenues for the development of new treatments for this debilitating complication of T2DM. Video abstract.
Keyphrases
- cell proliferation
- endoplasmic reticulum stress
- cell death
- oxidative stress
- transcription factor
- type diabetes
- cognitive decline
- early onset
- cell cycle arrest
- cancer therapy
- pi k akt
- metabolic syndrome
- signaling pathway
- glycemic control
- insulin resistance
- fluorescent probe
- climate change
- cerebral ischemia
- mild cognitive impairment